Liquid biopsy, initially for lung and breast cancer patients, can rapidly match treatment to specific tumour
Thousands of cancer patients in England are to benefit from a DNA blood test that saves lives by fast-tracking them on to personalised treatments.
In a world-first, the NHS will offer patients with lung and breast cancer – two of the most common forms of the disease – a liquid biopsy that detects tiny fragments of tumour DNA.
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
DNA testing firm 23andMe fined £2.3m by UK regulator for 2023 data hack